Klotho Therapeutics, Inc
Klotho Therapeutics, Inc. is a privately held biotechnology company developing modified recombinant human Klotho proteins, initially targeting slowing progression of kidney failure and with broader potential in aging-related diseases. Search results also include Klotho Skin, a separate skincare business using Klotho-related biotechnology; its relationship to Klotho Therapeutics is unclear.